Promoter structure and transcription initiation sites of the human death receptor 5/TRAIL-R2 gene.
about
CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cellsTranscription initiation sites and promoter structure of the human TRAIL-R3 geneTranscription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1.Poly(ADP-ribose) polymerase inhibitors sensitize cancer cells to death receptor-mediated apoptosis by enhancing death receptor expression.Systems analysis of ATF3 in stress response and cancer reveals opposing effects on pro-apoptotic genes in p53 pathway.The characterization of the human Siah-1 promoter(1).Hepatitis C virus sensitizes host cells to TRAIL-induced apoptosis by up-regulating DR4 and DR5 via a MEK1-dependent pathwayMedicarpin, a legume phytoalexin sensitizes myeloid leukemia cells to TRAIL-induced apoptosis through the induction of DR5 and activation of the ROS-JNK-CHOP pathway.Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation.Novel insights into the synergistic interaction of a thioredoxin reductase inhibitor and TRAIL: the activation of the ASK1-ERK-Sp1 pathway.TRAIL-induced apoptosis is enhanced by heat shock protein 70 expressionWogonin and related natural flavones overcome tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein resistance of tumors by down-regulation of c-FLIP protein and up-regulation of TRAIL receptor 2 expression.Kinetics of DNA methylation inheritance by the Dnmt1-including complexes during the cell cycle.Cardamonin sensitizes tumour cells to TRAIL through ROS- and CHOP-mediated up-regulation of death receptors and down-regulation of survival proteins.Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesisLow-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cellsThe role of TRAIL death receptors in the treatment of hematological malignancies.Roles Each of Snail, Yin Yang 1 and RKIP in the Regulation of Tumor Cells Chemo-immuno-resistance to Apoptosis.Combined modality therapy with TRAIL or agonistic death receptor antibodies.Resistance to TRAIL and how to surmount it.Sp1 and the 'hallmarks of cancer'.Characterization and promoter analysis of the mouse nestin gene.Inhibition of Notch1 signaling overcomes resistance to the death ligand Trail by specificity protein 1-dependent upregulation of death receptor 5.Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancerMyeloid zinc finger 1 mediates sulindac sulfide-induced upregulation of death receptor 5 of human colon cancer cells.Etoposide sensitizes neuroblastoma cells expressing caspase 8 to TRAIL.Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors.BCR-ABL regulates death receptor expression for TNF-related apoptosis-inducing ligand (TRAIL) in Philadelphia chromosome-positive leukemia.Aclarubicin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis through death receptor 5 upregulation.Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells.IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathway.Inhibition of Yin Yang 1-dependent repressor activity of DR5 transcription and expression by the novel proteasome inhibitor NPI-0052 contributes to its TRAIL-enhanced apoptosis in cancer cells.Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs.Translational control of tumor necrosis factor-related apoptosis-inducing ligand death receptor expression in melanoma cells.Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole.Silibinin sensitizes TRAIL-mediated apoptosis by upregulating DR5 through ROS-induced endoplasmic reticulum stress-Ca2+-CaMKII-Sp1 pathway.
P2860
Q24301679-4531C9A8-0834-4E62-BF91-55947A52DDDEQ28213507-90305BF0-12A9-4C05-8FB8-501A91F1DC95Q33862991-816C8283-83C2-4F78-A691-EB2E3A30E25FQ33947014-842A79A3-9DDD-422F-B1B1-7FC6231DF9D2Q34064732-9B6C6016-93F6-42FA-9E85-50641B7C4294Q34114807-6580344B-89B4-4D36-8BE8-0865CDECE189Q34291165-65501FD0-2BC7-427D-8138-4000E2D6ED55Q34541614-A448E608-554A-40E9-B5C8-AC358A8AB92DQ34722445-7720700A-8015-4EFC-9FB3-40D3E5AC81DFQ34734032-358A01CB-9BB2-460C-B49A-610A07FFC386Q35239558-0B1995CA-FC82-4632-9CDE-EE059477CDE7Q35643815-9936AE31-3087-4852-B322-2C2BAB10C417Q35839338-2999942B-6AB5-4BE4-9FAC-1DC616B4D755Q35859789-C412DE73-3C6E-4A44-8806-6BF8AED50A35Q36473635-CF7FC855-629F-4993-8D8D-64E085825E6BQ36909502-2CECD26A-A762-4378-83E3-5178F485BE7AQ37059750-BE7A1F05-1DE7-4FDF-8517-32E34D54E941Q37262987-793B9DA9-77CB-4E86-B92A-79E795B30054Q37832083-D111E42A-6CAF-4D9C-9CCB-9540D2363691Q37992546-B0E06000-8250-446C-89F1-C106DE99FEF1Q38267908-0A1875AF-5C83-46D5-910E-B6EDD84325ADQ38341421-54E485B2-B37E-4EB7-998C-06D3CC03994CQ38827688-D53CB035-C215-4927-AC22-D5F8092CBEE8Q38839654-64F24922-427F-4E65-9C57-94CA5D448BE2Q38968034-99E51784-1026-4391-B583-3A74269DA95BQ39249745-FE544A74-7BEC-42BB-8527-0ED0267BF205Q39323262-2F7023C1-EA05-4FC8-8A47-B4CF852CA466Q39337116-A99FFD4B-DD5E-406F-B09D-409355EE93CCQ39444362-E12EB9A9-2F7C-4483-9A6B-A28D951D3456Q39472164-1B8E66D1-488F-4CC9-9728-9C7984CD5209Q39912926-57EB13A1-2543-4F6E-9E82-AD93C920DA9BQ39990380-9CD68598-7407-4C01-98C7-F46E5DE1ED67Q40311561-311EC489-9923-4A1C-8A45-8009BCA39C18Q40605290-8AA254BF-BD7B-4FE8-87B6-8A35358F05C2Q46809704-F94199C3-BC54-4E30-8DAB-8368F737476CQ53079276-B7F38D8A-6E51-47DF-BF39-41B469329ECA
P2860
Promoter structure and transcription initiation sites of the human death receptor 5/TRAIL-R2 gene.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Promoter structure and transcr ...... eath receptor 5/TRAIL-R2 gene.
@en
Promoter structure and transcr ...... eath receptor 5/TRAIL-R2 gene.
@nl
type
label
Promoter structure and transcr ...... eath receptor 5/TRAIL-R2 gene.
@en
Promoter structure and transcr ...... eath receptor 5/TRAIL-R2 gene.
@nl
prefLabel
Promoter structure and transcr ...... eath receptor 5/TRAIL-R2 gene.
@en
Promoter structure and transcr ...... eath receptor 5/TRAIL-R2 gene.
@nl
P2093
P2860
P1433
P1476
Promoter structure and transcr ...... eath receptor 5/TRAIL-R2 gene.
@en
P2093
P2860
P304
P356
10.1016/S0014-5793(01)02947-7
P407
P577
2001-11-01T00:00:00Z